Biogen Inc.

Healthcare

NASDAQ:BIIB · NASDAQ Global Select

Market Cap $29.53B Beta 0.18 P/E (TTM) 21.5

$200.05 +0.05%

+$0.09 today

52W Low $121.05High $205.97

Vol 0.84M · Avg 1.17M

EPS (TTM)$9.32

Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+53.12%

Period High

$204.53

Period Low

$122.68

Latest

$200.05

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Teva Pharmaceutical Industries Limited

NYSE:TEVA

$40.32B

DexCom, Inc.

NASDAQ:DXCM

$29.08B

Waters Corporation

NYSE:WAT

$23.17B

United Therapeutics Corporation

NASDAQ:UTHR

$23.17B

Quest Diagnostics Incorporated

NYSE:DGX

$22.48B

Labcorp Holdings Inc.

NYSE:LH

$21.83B

Incyte Corporation

NASDAQ:INCY

$21.68B

STERIS plc

NYSE:STE

$20.26B

Genmab A/S

NASDAQ:GMAB

$15.40B

Insulet Corporation

NASDAQ:PODD

$10.37B

What is the latest BIIB filing?

The latest filing shown is 4 dated Jun 11, 2026.

How many recent filings does BIIB have?

Intrinsic Alpha currently shows 20 recent filings for BIIB.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.